PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MYOCYPATIA COMPRISING A Glucagon-like Peptide-1 Receptor Promoter

摘要

The present invention relates to glucagon-like peptide-1 (GLP-1), GLP-1 fragment, GLP-1 secretion increase promoter, GLP-1 degradation inhibitor, GLP-1 receptor (GLP-1R) enhancer, or exendin The present invention relates to a pharmaceutical composition for preventing or treating muscular atrophy or muscular atrophy comprising -4, and a method for treating muscular atrophy or myopathy using the pharmaceutical composition. When the pharmaceutical composition for preventing or treating muscular atrophy or sarcopenia provided by the present invention is administered to an individual who has developed muscular atrophy or sarcopenia, the weight decreased due to muscular atrophy or sarcopenia, Since the expression level of genes involved in skeletal muscle weight, grip strength and muscle generation can be restored to a normal state, it will be widely used in the development of effective therapeutic agents for muscle atrophy or myopathy. [Selection] FIG.